INCORPORATING CELL PROLIFERATION IN QUANTITATIVE CANCER RISK ASSESSMENT: APPROACHES, ISSUES, AND UNCERTAINTIES
Notice - This site contains archived material(s)
Archive disclaimer
Archive
disclaimer
Archived files are provided for reference
purposes only. These files are no longer maintained by the Agency and may be outdated. For
current EPA information, go to www.epa.gov. It is EPA's policy to
support reasonable accommodation to persons with disabilities, pursuant to the Rehabilitation
Act of 1973, 29 U.S.C. 791. If you need assistance with accessing archived files, contact
EPA's Reasonable Accommodations
or submit a request using the Contact Us form.
Abstract
A two-stage tumor growth model that explicitly incorporates mitoticrate of initiated cells is developed. s an example, the model isapplied to data from dinitrotoluene (DNT) studies to demonstratehow information on preneoplastic and neoplastic lesions can beincorporated into the dose-response model, to critically examineits implication for (quantitative risk assessment, and to simulateissues, problems, and data gaps that may arise when one attempts toincorporate cell proliferation into the quantitative riskestimation.
Citation
Chen, C. AND W. Farland. INCORPORATING CELL PROLIFERATION IN QUANTITATIVE CANCER RISK ASSESSMENT: APPROACHES, ISSUES, AND UNCERTAINTIES. U.S. Environmental Protection Agency, Washington, D.C., EPA/600/D-90/148 (NTIS PB90263146), 1990.
Additional Information
Presented at Symposium - Chemically Induced Cell Proliferation:Implications for Risk Assessment, November 29-December 2, 1989,Austin, Texas